Capricorn Fund Managers’s Mirum Pharmaceuticals MIRM Stock Holding History

Capricorn Fund Managers’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.9M	Buy	+101,240	New	+$10.2M	0.93%	35

Other funds holding MIRM

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Capricorn Fund Managers's MIRM Position: Q2 2026 in Review

Capricorn Fund Managers opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 101,240 shares worth $11.9M. The stake represents 0.93% of the portfolio and ranks #35 among its holdings.

45 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Capricorn Fund Managers held 101,240 shares of Mirum Pharmaceuticals worth $11.9M as of Q2 2026.
Mirum Pharmaceuticals was a new Capricorn Fund Managers position in Q2 2026.
Mirum Pharmaceuticals made up 0.93% of Capricorn Fund Managers's portfolio in Q2 2026, its #35 holding.
45 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.